Cullinan Therapeutics Inc.

10/16/2024 | Press release | Distributed by Public on 10/16/2024 05:18

Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic[...]